Patient characteristics
| Characteristic . | n = 459 . |
|---|---|
| Age at diagnosis, y | |
| Median (Q1, Q3) | 65 (58, 73) |
| < 50 | 41 (9) |
| 50-60 | 121 (26) |
| 61-70 | 141 (31) |
| > 70 | 156 (34) |
| Sex | |
| Male | 278 (61) |
| Female | 181 (39) |
| Median ALC at diagnosis, ×109/L (Q1, Q3) | 8.8 (6.5, 14.2) |
| Median B-cell count at diagnosis, ×109/L (Q1, Q3) | 5.9 (3.7, 11.2) |
| ALC at diagnosis, ×109/L | |
| < 10.0 | 272 (59) |
| 10.0-25.0 | 145 (32) |
| > 25.0-50.0 | 30 (7) |
| > 50.0 | 13 (3) |
| CD38 | |
| Positive, ≥ 30% | 83 (19) |
| Negative, < 30% | 355 (81) |
| Missing | 21 |
| ZAP-70 | |
| Positive, ≥ 20% | 63 (23) |
| Negative, < 20% | 215 (77) |
| Missing | 181 |
| IGHV gene mutation status | |
| Unmutated | 87 (31) |
| Mutated | 190 (69) |
| Missing | 182 |
| FISH result | |
| 13q− | 149 (50) |
| Normal | 81 (27) |
| +12 | 42 (14) |
| 11q− | 16 (5) |
| 17p− | 11 (4) |
| Other (6q−) | 2 (1) |
| Missing | 158 |
| Characteristic . | n = 459 . |
|---|---|
| Age at diagnosis, y | |
| Median (Q1, Q3) | 65 (58, 73) |
| < 50 | 41 (9) |
| 50-60 | 121 (26) |
| 61-70 | 141 (31) |
| > 70 | 156 (34) |
| Sex | |
| Male | 278 (61) |
| Female | 181 (39) |
| Median ALC at diagnosis, ×109/L (Q1, Q3) | 8.8 (6.5, 14.2) |
| Median B-cell count at diagnosis, ×109/L (Q1, Q3) | 5.9 (3.7, 11.2) |
| ALC at diagnosis, ×109/L | |
| < 10.0 | 272 (59) |
| 10.0-25.0 | 145 (32) |
| > 25.0-50.0 | 30 (7) |
| > 50.0 | 13 (3) |
| CD38 | |
| Positive, ≥ 30% | 83 (19) |
| Negative, < 30% | 355 (81) |
| Missing | 21 |
| ZAP-70 | |
| Positive, ≥ 20% | 63 (23) |
| Negative, < 20% | 215 (77) |
| Missing | 181 |
| IGHV gene mutation status | |
| Unmutated | 87 (31) |
| Mutated | 190 (69) |
| Missing | 182 |
| FISH result | |
| 13q− | 149 (50) |
| Normal | 81 (27) |
| +12 | 42 (14) |
| 11q− | 16 (5) |
| 17p− | 11 (4) |
| Other (6q−) | 2 (1) |
| Missing | 158 |
All values are no. (%) unless otherwise indicated.